Public procurement notice: Contract Notice
Published: 2017-02-24
Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) (‘the Authority’)
Country: UK
Region: SCOTLAND
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33141520 | 33600000: Pharmaceutical products | 33651520
Estimated value: 78000000 GBP
Submission deadline: 2017-03-27
Award criteria: The most economic tender

Technical requirements: This Framework Agreement is for the supply of Intravenous Immunoglobulin (IVIgG) and Subcutaneous Immunoglobulin (IgG).
All deliveries under the framework agreement will be to one central location, namely ‘The Scottish National Blood Transfusion Service’ (SNBTS), Edinburgh.
Supply of Human Normal Intravenous Immunoglobulin 5 %, across various vial sizes including current Primary Immune Deficiencies (PID) usage.
This lot will be awarded as a Ranked Multi Supplier Framework. It is envisaged that a maximum of six (6) suppliers will be awarded to this lot.
The Authority is entitled at its sole discretion to extend the twenty four (24) month duration of the Framework Agreement by two (2) periods of up to twelve (12) months each by giving a minimum of three (3) months written notice of such extension.
Supply of Human Normal Intravenous Immunoglobulin 10 %, across various vial sizes including current Primary Immune Deficiencies (PID) usage.
This lot will be awarded as a Ranked Multi Supplier Framework. It is envisaged that a maximum of six (6) suppliers will be awarded to this lot.
The Authority is entitled at its sole discretion to extend the twenty four (24) month duration of the Framework Agreement by two (2) periods of up to twelve (12) months each by giving a minimum of three (3) months written notice of such extension.
Supply of Human Normal Intravenous Immunoglobulin for subcutaneous use across various vial sizes including current Primary Immune Deficiencies (PID) usage.
This lot will be awarded as a Ranked Multi Supplier Framework. It is envisaged that a maximum of six (6) suppliers will be awarded to this lot.
The Authority is entitled at its sole discretion to extend the twenty four (24) month duration of the Framework Agreement by two (2) periods of up to twelve (12) months each by giving a minimum of three (3) months written notice of such extension.
Supply of Subcutaneous Immunoglobulin with Hyaluronidase. The Authority intends awarding all presentations within this Lot to a single supplier.
The Authority is entitled at its sole discretion to extend the twenty four (24) month duration of the Framework Agreement by two (2) periods of up to twelve (12) months each by giving a minimum of three (3) months written notice of such extension.
Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.
(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by approved by the MHRA for all tendered Medicines at the date of submission of the tender.

Eligibility requirements: Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.

Award value: 78000000